Key articles and guidelines for the emergency medicine clinical pharmacist: 2011-2018 update.


Journal

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
ISSN: 1535-2900
Titre abrégé: Am J Health Syst Pharm
Pays: England
ID NLM: 9503023

Informations de publication

Date de publication:
07 08 2020
Historique:
entrez: 9 8 2020
pubmed: 9 8 2020
medline: 28 5 2021
Statut: ppublish

Résumé

To summarize recently published research reports and practice guidelines on emergency medicine (EM)-related pharmacotherapy. Our author group was composed of 14 EM pharmacists, who used a systematic process to determine main sections and topics for the update as well as pertinent literature for inclusion. Main sections and topics were determined using a modified Delphi method, author and peer reviewer groups were formed, and articles were selected based on a comprehensive literature review and several criteria for each author-reviewer pair. These criteria included the document "Oxford Centre for Evidence-based Medicine - Levels of Evidence (March 2009)" but also clinical implications, interest to reader, and belief that a publication was a "key article" for the practicing EM pharmacist. A total of 105 articles published from January 2011 through July 2018 were objectively selected for inclusion in this review. This was not intended as a complete representation of all available pertinent literature. The reviewed publications address the management of a wide variety of disease states and topic areas that are commonly found in the emergency department: analgesia and sedation, anticoagulation, cardiovascular emergencies, emergency preparedness, endocrine emergencies, infectious diseases, neurology, pharmacy services and patient safety, respiratory care, shock, substance abuse, toxicology, and trauma. There are many important recent additions to the EM-related pharmacotherapy literature. As is evident with the surge of new studies, guidelines, and reviews in recent years, it is vital for the EM pharmacist to continue to stay current with advancing practice changes.

Identifiants

pubmed: 32766731
pii: 5881865
doi: 10.1093/ajhp/zxaa178
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1284-1335

Informations de copyright

© American Society of Health-System Pharmacists 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Nicole M Acquisto (NM)

Department of Pharmacy and Department of Emergency Medicine, University of Rochester Medical Center, Rochester, NY.

Giles W Slocum (GW)

Department of Pharmacy, Rush University Medical Center, Chicago, IL.

Matthew H Bilhimer (MH)

Department of Pharmacy, Olathe Medical Center, Olathe, KS.

Nadia I Awad (NI)

Department of Pharmacy, Robert Wood Johnson University Hospital, New Brunswick, NJ.

Stephanie Baker Justice (SB)

Department of Pharmacy, St. Claire Regional Medical Center, Morehead, KY.

Gregory F Kelly (GF)

Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA.

Therese Makhoul (T)

Department of Pharmacy, Santa Rosa Memorial Hospital, Santa Rosa, CA.

Asad E Patanwala (AE)

School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.

Gary D Peksa (GD)

Department of Pharmacy, Rush University Medical Center, Chicago, IL.

Blake Porter (B)

Department of Pharmacy, University of Vermont Medical Center, Burlington, VT.

Donna M Shuler Truoccolo (DMS)

Department of Pharmacy, University of Virginia Health System, Charlottesville, VA.

Cierra N Treu (CN)

Department of Pharmacy, NewYork Presbyterian-Brooklyn Methodist Hospital, Brooklyn, NY.

Kyle A Weant (KA)

Medical University of South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, SC.

Michael C Thomas (MC)

McWhorter School of Pharmacy, Samford University, Birmingham, AL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH